20 Aug Topical Ivermectin for Rosacea: What the Phase 3 Evidence Actually Shows
Posted at 23:24h
in Dermatology
Ivermectin is better known as an oral antiparasitic, so its arrival as a first-line topical treatment for papulopustular rosacea took some clinicians by surprise. The evidence base behind that shift is unusually clean for dermatology: a large head-to-head trial against an established comparator, a controlled extension measuring relapse, and long-term safety data against a second active agent.